John A. Olson

15.0k total citations · 2 hit papers
87 papers, 6.4k citations indexed

About

John A. Olson is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, John A. Olson has authored 87 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in John A. Olson's work include Breast Cancer Treatment Studies (21 papers), Retinal Diseases and Treatments (15 papers) and Retinal Imaging and Analysis (13 papers). John A. Olson is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), Retinal Diseases and Treatments (15 papers) and Retinal Imaging and Analysis (13 papers). John A. Olson collaborates with scholars based in United States, United Kingdom and Canada. John A. Olson's co-authors include Jeffrey R. Marks, Holly K. Dressman, Joseph R. Nevins, Mike West, Peter F. Sharp, K C McHardy, Keith A. Goatman, Carrie Blanchette, Johnathan M. Lancaster and Dawn A. D. Chasse and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

John A. Olson

85 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

2005 1.5k citations John A. Olson, Jeffrey R. Marks et al. profile →
Predicting the clinical status of human breast cancer by using gene expression profiles

2001 988 citations Holly K. Dressman, John A. Olson et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Olson United States	37	2.7k	1.6k	1.5k	1.4k	1.1k	87	6.4k
David Capper Germany	58	5.2k 1.9×	3.4k 2.1×	2.6k 1.7×	1.9k 1.4×	332 0.3×	230	13.4k
Matija Snuderl United States	40	3.2k 1.2×	2.2k 1.4×	2.2k 1.4×	1.7k 1.2×	87 0.1×	188	9.2k
Matthew S. Brown United States	50	3.0k 1.1×	871 0.5×	773 0.5×	2.1k 1.5×	69 0.1×	154	8.3k
Ming Y. Lu United States	33	1.3k 0.5×	430 0.3×	378 0.3×	1.4k 1.0×	473 0.4×	76	4.7k
Haiquan Chen China	47	2.0k 0.7×	1.5k 0.9×	2.9k 1.9×	1.2k 0.9×	104 0.1×	236	7.6k
Hui‐Kuo G. Shu United States	45	2.0k 0.7×	927 0.6×	1.3k 0.9×	1.3k 1.0×	42 0.0×	236	7.2k
Daniel J. Booser United States	44	2.3k 0.9×	3.5k 2.1×	5.2k 3.4×	1.0k 0.8×	136 0.1×	105	8.1k
Craig H. Mermel United States	24	4.5k 1.6×	3.0k 1.9×	2.1k 1.4×	808 0.6×	33 0.0×	31	8.0k
Johan Hartman Sweden	34	2.7k 1.0×	1.9k 1.1×	2.4k 1.6×	835 0.6×	35 0.0×	113	6.7k
Kurt A. Schalper United States	52	2.7k 1.0×	1.4k 0.9×	7.0k 4.7×	1.3k 1.0×	52 0.0×	166	11.2k

Countries citing papers authored by John A. Olson

Since Specialization

Citations

This map shows the geographic impact of John A. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Olson more than expected).

Fields of papers citing papers by John A. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Olson. The network helps show where John A. Olson may publish in the future.

Co-authorship network of co-authors of John A. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Olson. A scholar is included among the top collaborators of John A. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Olson. John A. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McDonald, Eli Fritz, et al.. (2025). Proteostasis landscapes of cystic fibrosis variants reveal drug response vulnerability. Proceedings of the National Academy of Sciences. 122(17). e2418407122–e2418407122. 2 indexed citations

Olson, John A., Eli Fritz McDonald, Jens Meiler, et al.. (2025). General trends in the calnexin-dependent expression and pharmacological rescue of clinical CFTR variants. eLife. 14.

Sparano, Joseph A., Robert J. Gray, Della Makower, et al.. (2023). Abstract GS1-05: Trial Assigning Individualized Options for Treatment (TAILORx): An Update Including 12-Year Event Rates. Cancer Research. 83(5_Supplement). GS1–5. 4 indexed citations

Dospinescu, Paula, Rosemary Hollick, Cosimo De Bari, et al.. (2020). Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis. Rheumatology Advances in Practice. 4(2). rkaa024–rkaa024. 6 indexed citations

Doostan, Iman, Cansu Karakaş, Matthew J. Ellis, et al.. (2017). Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer. Clinical Cancer Research. 23(23). 7288–7300. 35 indexed citations

Haricharan, Svasti, Purba Singh, Kimberly R. Holloway, et al.. (2017). Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. Cancer Discovery. 7(10). 1168–1183. 50 indexed citations

Augustine, Christina K., Sin‐Ho Jung, Insuk Sohn, et al.. (2010). Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma. Molecular Cancer Therapeutics. 9(4). 779–790. 19 indexed citations

Barry, William T., Dawn Kernagis, Holly K. Dressman, et al.. (2010). Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome. Journal of Clinical Oncology. 28(13). 2198–2206. 84 indexed citations

Crowder, Robert J., Chanpheng Phommaly, Tao Yu, et al.. (2009). PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 69(9). 3955–3962. 174 indexed citations

10.

Ellis, Matthew J., Lin Li, Robert J. Crowder, et al.. (2009). Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. 119(2). 379–390. 110 indexed citations

11.

Horne, Hisani N., Paula S. Lee, Susan K. Murphy, et al.. (2009). Inactivation of the MAL Gene in Breast Cancer Is a Common Event That Predicts Benefit from Adjuvant Chemotherapy. Molecular Cancer Research. 7(2). 199–209. 38 indexed citations

12.

Zhai, Jun, Brian R. Untch, Matthew J. Ellis, et al.. (2009). Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care. Breast Cancer Research and Treatment. 118(3). 635–43. 7 indexed citations

13.

Ellis, Matthew J., Jingqin Luo, Yu Tao, et al.. (2009). Tumor Ki67 Proliferation Index within 4 Weeks of Initiating Neoadjuvant Endocrine Therapy for Early Identification of Non-Responders.. Cancer Research. 69(24_Supplement). 78–78. 6 indexed citations

14.

Olson, John A., Thomas Budd, Lisa A. Carey, et al.. (2009). Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial. Journal of the American College of Surgeons. 208(5). 906–914. 65 indexed citations

15.

Fleming, Alan, John A. Olson, Sam Philip, et al.. (2008). Manual vs. automated: the diabetic retinopathy screening debate. 3 indexed citations

16.

Untch, Brian R. & John A. Olson. (2006). Anaplastic Thyroid Carcinoma, Thyroid Lymphoma, and Metastasis to Thyroid. Surgical Oncology Clinics of North America. 15(3). 661–679. 23 indexed citations

17.

Olson, John A., John H. Hipwell, Keith A. Goatman, et al.. (2003). A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabetic Medicine. 20(7). 528–534. 130 indexed citations

18.

Knott, Rachel M., J. B. Leiper, John A. Olson, et al.. (1999). Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy. Metabolism. 48(9). 1172–1178. 9 indexed citations

19.

Undrill, P.E., Michael J. Cree, John A. Olson, et al.. (1998). A comparison of computer based classification methods applied to the detection of microaneurysms in ophthalmic fluorescein angiograms. Computers in Biology and Medicine. 28(3). 225–238. 162 indexed citations

20.

Olson, John A., Mary K. DeBenedetti, Dirk S. Baumann, & Samuel A. Wells. (1996). Parathyroid Autotransplantation During Thyroidectomy. Annals of Surgery. 223(5). 472–480. 223 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact